cellPrism® Drug Development Platform

A Spectrum of Customizable Assays in one Drug Development Platform

 Cell Prism

About cellPrism®

cellPrism® is a drug development platform offering customizable cell-based in vitro assays using optimally sourced and processed primary cells (blood and bone marrow cells) from multiple species. By using primary cells in our assays we’re able to provide clients with the best clinically relevant data, including high content readouts for numerous blood diseases and disorders. Our predictive assays can be applied to a variety of program challenges including neutropenia, thrombocytopenia, and immuno-oncology.


Click the image for a larger view.

Click here for a print version of cellPrism®